Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 1 Hunting intracellular bacteria with antibiotics Paul M. Tulkens,

Slides:



Advertisements
Similar presentations
Pharmacology and development of Antibiotics (Penicillin) and Antiseptics 13/02/13 By: Mohit Kumar Sharma PhD Final year.
Advertisements

Immunity to bacteria Barrier defenses of human body.
Staphylococcus Department of pathogenic Biology of Gannan Medical College.
5/20/2015ISAP Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ? Sandrine Lemaire Université catholique.
Pharmacodynamics of Antibiotics
Environmental Factors that Influence Microbes Including Antimicrobial Agents.
Antimicrobial compounds Antiseptics and disinfectants Antibiotics.
Penicillin and Cephalosprin: Beta- Lactam Antibiotics and Other Inhibitors of Cell Wall Synthesis by Dena Nguyen
PHL 424 Antimicrobials 5 th Lecture By Abdelkader Ashour, Ph.D. Phone:
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.
Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.
Agents for the Treatment of MRSA: Pharmakokinetics &Pharmacodynamics
Jacob Greenlee and Dr. John Willford Departments of Molecular Biology and Microbiology University of Wyoming April, 2011.
MACROLIDES: pharmacokinetics and pharmacodynamics
Hunting intracellular bacteria with antibiotics
Bacterial persistence
Setting-up a model of intracellular infection by Pseudomonas aeruginosa for the pharmacodynamic evaluation of antibiotic activity. J. Buyck1, O. Jolois2,
studies with Caco-2 cells and THP-1 macrophages
Françoise Van Bambeke, PharmD, PhD
Intracellular Infection of THP-1 Human Macrophages by Staphylococcus aureus and Role of Haemolysins Mailling adresse: Aurélie Olivier.
The Staphylococci.
Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.
Intracellular antibiotics and Listeria monocytogenes
Françoise Van Bambeke & Paul M. Tulkens
In vitro pharmacodynamic models for the study of antibiotic activity against bacterial biofilms Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire.
Frédéric Peyrusson, Françoise Van Bambeke, Paul M. Tulkens
Intracellular Antibiotics : what does it (really) mean ?
Accumulation, Release and Subcellular Distribution of the Peptide Deformylase Inhibitor GSK in Murine Macrophages (J774) and Human Monocytes (THP-1)
Activity of 9 antibiotics against intracellular forms of S. pneumoniae
Pharmacokinetics of Old and New Glycopeptides
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
Oritavancin Kills S. aureus by Increasing Membrane Permeability without Causing Extensive Cell Lysis: Comparative Studies with Vancomycin, Daptomycin,
This poster will be made available for download after the meeting at :
Intracellular Bacterial Infections: Why Are Antibiotics Poorly Efficient and Can We Do Something About it ? Paul M. Tulkens, MD, PhD * Cellular and Molecular.
Université catholique de Louvain
Introduction Results Aim Methods References Conclusion
Background and objectives
Université catholique de Louvain, Brussels, Belgium
Emilien Drouot, Paul M. Tulkens, Françoise Van Bambeke
Antibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria Françoise Van Bambeke on behalf of J.M. Michot,
Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology Unit
Extracellular activity Intracellular activity
New antistaphlycoccal agents: Hopes and limitations
Antibiotics in bone and joint infections
Abstract Results Methods Background Conclusions References
cellular accumulation (24h) Cstatic (LZD/RDZ ratio)
Updates on treatment of Staphylococcus aureus / MRSA
52 - Antimicrobials Radezolid (RX-1741), a Novel Oxazolidinone, Accumulates Extensively within Human Macrophages and PMNs and Shows Activity towards.
Of a Pig-related ST-398 Methicillin-Resistant S. aureus (A-MRSA)
EV0626 Cellular pharmacokinetics of gepotidacin (GSK )
Abstract Results Aim of the study Methods Background Conclusions
Difference log CFU from time 0
Log extracellular concentration (mg/L)
Activity of Moxifloxacin against Staphylococcus aureus in Models of Persistent Infections (Intracellular Survival, Biofilms) Mailing address: P.M. Tulkens.
F. Van Bambeke & P.M. Tulkens
Staph Infection and MRSA Staphylococcus aureus
Rega Institute : my research contacts …
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Intracellular antibiotics
Françoise Van Bambeke, Dr Sc. Pharm, Agr. Ens. Sup.
Intracellular models of infection to evaluate antibiotic activity
Models of Intracellular Antibiotic Transport
Chemotherapy and PK/PD of intracellular infections
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Pharmacodynamic indices in targeting therapy of critical infections
Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van.
Are intracellular drug concentrations relevant for efficacy
Presentation transcript:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 1 Hunting intracellular bacteria with antibiotics Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology Unit & Centre for Clinical Pharmacy Louvain Drug Research Institute Catholic University of Louvain, Brussels, Belgium

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 2 But before that, where are you from ? slides are available on  Lectures Belgium Brussels The medical campus of the Université catholique de Louvain The Cellular and Molecular Pharmacology Group

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 3 Intracellular infection: bacterial strategies Carryn et al. Infect Dis Clin North Am. 2003;17:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 4 Intracellular infection and recurrence/relapses: the case of S. aureus (as an example)

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 5 Intracellular infection and recurrence/relapses: the case of S. aureus (as an example) Phagocytic and non phagocytic cells in mastitis Brouillette et al., Microb. Pathog. (2003) 35:159-68

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 6 A real need... Pharmacochemistry and Biology to your help ! Staphyloxanthin and intracellular survival Activity of availailable antibiotics What for the future ?

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 7 Settting up the model … Seral et al. Antimicrob. Agents Chemother :

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 8 S. aureus virulence factors EbpS ClfA ClfB FnBPA FnBPB SpA IgG vWF elastin fibrinogen fibronectin Cna collagen staphyloxanthin Diseases-related toxins Hemolysins Hla Hlb Hlg tissues necrosis and inflammation Hld Coa Degradatives enzymes S. aureus Eukaryotic cell internalization α 5 β 1 integrin nucleases proteases lipases collagenase hyaluronidase prothrombin KatA H2O2H2O2 H2OH2O Adhesion – Invasion (early steps of infection) Protection vs. host defenses Colonization - Degradation - Nutrition (late steps of infection) PVL SEs ETs TSST-1 Toxic shock syndrome Food poisoning Skin infections & necrotizing pneumonia Scald skin syndrome & impetigo Olivier et al., Role of virulence factors in S. aureus infections. Submitted

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 9 S. aureus virulence factors A.C. Olivier. Intracellular fate of Staphylococcus aureus in human phagocytic and non phagocytic cells and role of virulence factors. PhD Thesis, 2008

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 10 Staphyloxanthin synthesis

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 11 Our material…. 2 isogenic strains rsbu - and rsbu + inhibitors of staphyloxanthin synthesis * Olivier et al. J. Infect. Dis. (2009) 200: * made by E. Oldfield, Champaign, IL

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 12 The results…. Olivier et al. J. Infect. Dis. (2009) 200:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 13 And with other strains…. the more staphyloxanthin is produced, the more successful is the strain for intracellular growth … blocking staphyloxanthin synthesis makes all strain equally ill-successful… Olivier et al. J. Infect. Dis. (2009) 200:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 14 Antibiotics and intracellular infection… Carryn et al. Infect Dis Clin North Am Sep;17(3):

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 15  -lactams: a pharmacokinetic paradox beta-lactams:  1x aminoglycosides: <1 to 2 x ansamycins: 2-3 x tetracyclines: 2-4 x fluoroquinolones: x macrolides: 4 to > 100 x Accumulation of antibiotics in macrophages Tulkens PM, Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis. 1991; 10:100-6

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 16  -lactams and S. aureus... (MSSA) Lemaire et al., JAC 55: , 2005 extracellular intracellular E max CsCs CsCs

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 17 The intracellular pharmacodynamic paradox of  -lactams… Hint: pH in vacuoles is acidic Lemaire et al., AAC (2007) 51:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 18 Back to the future…

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 19 Biochemistry comes to your help…

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 20 Acid pH favors penicillin binding to PBP2a Lemaire et al., JBC (2008) 283:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 21 Acid pH favors oxacillin-induced conformational change in PBP2a Lemaire et al., JBC (2008) 283:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 22 Screening available antibiotics Barcia-Macay et al. Antimicrob. Agents Chemother. 2006, in press

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 23 New glycopeptides (oritavancin,telavancin, dalbavancin)… Phase III, Theravance  Astellas Awaiting FDA approval, Vicuron  Pfizer Van Bambeke, Current Opinion in Pharmacology (2004) 4: Hemi-synthetic derivatives derived from vancomycin teicoplanin Phase III, Intermune  Targenta

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 24 Telavancin (and oritavancin) new modes of action … Possibility of dimerization  potential increase of intrinsic activity against D-Ala-D-Ala displaying organisms (MSSA, MRSA, VISA) Membrane destabilization effects…  strong concentration-dependent bactericidal effect (all strains...) * Beauregard et al., AAC 1995; 39:781-85

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 25 Telavancin … lipophilic side chain polar group VAN TLV this causes increase in bacterial membrane permeability Higgins et al., Antimicrob Agents Chemother. (2005) 49:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 26 Telavancin intracellular accumulation and subcellular disposition Van Bambeke et al., unpublished

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 27 Intracellular activity of telavancin vs. vancomycin:  MSSA  MRSA Barcia-Macay et al., JAC, in the press 24h CFU  at C max : vanco:  0.5 log TLV:  2 log

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 28 Barcia-Macay et al., JAC, in the press 24h CFU  at C max : vanco: static TLV:  1.2 log Intracellular activity of telavancin vs. vancomycin:  VISA  VRSA

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 29 Telavancin intracellular activity in comparison with other drugs… Lemaire et al., ISSSI 2006 – Sept. 3-6, 2006

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 30 SCVs of S. aureus as a cause of persistent foreign body infection

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 31 Intracellular SCVs…

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 32 Intracellular SCVs and antibiotics … it's hard to exceed 2 log drop… Perhaps due to membrane-detabilization effect … Domenech et al. Biochim Biophys Acta : Baudoux et al. ICAAC 2009 [C1-1354] Nguyen et al., Antimicrobial Agents and Chemotherapy (2009) 53:1434–1442

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 33 Will this be successful ?

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 34 And now Listeria… Carryn et al. Infect Dis Clin North Am. 2003;17:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 35 As if you were there … phagocytosis escape from vacuole in cytosol Ouadrhiri et al. Antimicrob Agents Chemother. 1999; 43:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 36 A surprise … ampicillin is MORE active intracellularly Lemaire et al. J Antimicrob Chemother. 2005; 55: E max

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 37 A potential explanation … through proteomics Van de Velde et al. Isolation and 2D-DIGE Proteomic Analysis of Intracellular Listeria monocytogenes in comparison with its extracellular form. Proteomics (2009) 9:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 38 What may change in intracellular Listeria… pyruvate citratefatty acids glutamate Synthesis of thiamine precursors synthesis ofdTDP-rhamnose UDP-glucose hexose transportersABC transporters teichoic acid lipoteichoic acid Oxidative stress response nucleotide synthesis synthesis of peptidoglycan metabolism of sugars/aminosugars/glycerolipids pentose phosphate pathway glyceraldehyde-3-P D-alanine D-Ala-D-Ala Van de Velde et al. Isolation and 2D-DIGE Proteomic Analysis of Intracellular Listeria monocytogenes in comparison with its extracellular form. Proteomics (2009) 9:

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 39 In a nutshell intracellular bacteria is a reality… antivirulence therapy is a nice project … most available antibiotics are poorly active against intracellular bacteria, … and if they are, they most often are less potent than against extracellular bacteria (be prepared for the worse) we may have good (but rare) surprises…

Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 40 Anyway, the intracellular infection kept us busy and happy … CristinaSeral Hoang Anh Nguyen Maritza Barcia- Macay Pierre Baudoux SandrineLemaire Aurélie Olivier Sébastien Van de Velde Françoise Van Bambeke In collaboration also with :  Y. Glupczynski, Cliniques universitaires de l'UCL à Mont-Godinne, Yvoir, Belgium  A. Vergison, O. Denis, M. Struelens, Hôpital Erasme, ULB, Brussels, Belgium  P. Appelbaum, Hershey Medical Center, Hershey, PA, USA  and many others… and many others